Skip to main content

Table 1 Demographic features of once- and twice-daily dosage groups

From: Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever – a randomized controlled noninferiority trial

Characteristic

Once-daily dosage group (n = 42)

Twice-daily dosage group (n = 37)

Age,a years

7.90 ± 1.96

7.78 ± 2.00

Sex, F/M

21/21

19/18

Age of disease onset,a years

5.14 ± 2.90

5.05 ± 3.04

Age of disease diagnosis,a years

7.54 ± 2.50

7.51 ± 2.66

Consanguinity, %

16.6

16.2

Presence of FMF in family members, %

59.5

62.2

  1. FMF familial Mediterranean fever
  2. aMean ± SD